Viewing Study NCT04893759


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2025-12-26 @ 9:13 PM
Study NCT ID: NCT04893759
Status: TERMINATED
Last Update Posted: 2025-04-17
First Post: 2021-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module